3rd Quarter - Report
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Income
—
Expenses
$70,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Initiatives. Newborn Screening.. Orphan Drug Act. FDA Modernization. FDA Initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL JOSEPH BEARD | — |
| KATHRYN LOWELL New | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Prescription Drug User Fee Act (PDUFA) Reauthorization. User Fee Agreements. Patient Experience Data.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL JOSEPH BEARD | — |
| KATHRYN LOWELL New | — |
Budget/Appropriations BUD
Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. Legislation on Accepting User Fees during a Lapse in Government Funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL JOSEPH BEARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.